- Guide to PHARMACOLOGY
Compound class: Synthetic organic
Comment: Compound 6 was discovered as part of the same structure-guided design campaign as dual BRD4/PLK1 inhibitor 23, but in contrast is selective for polo like kinase 1 (PLK1) over BRD4-BD1 . Dual BRD4/PLK1 inhibitor 23 and compound 6 will allow dissection of the contributions made by inhibition of each target to the desired anti-cancer potential of this polypharmacology approach.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Liu S, Yosief HO, Dai L, Huang H, Dhawan G, Zhang X, Muthengi AM, Roberts J, Buckley DL, Perry JA et al.. (2018)
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors.
J Med Chem, 61 (17): 7785-7795. [PMID:30125504]